Frontiers in Allergy | Drug, Venom & Anaphylaxis

Brief Research Report

Published on 07 Jan 2025

Challenges in diagnosing polyethylene glycol and polysorbate 80 allergies: implications for allergic reactions in COVID-19 mRNA vaccination program: experience from Qatar

in Drug, Venom & Anaphylaxis

Sami Aqel
Sherin Thalappil
Asaad Imameldin
Dalal Mudawi
Muna Al Maslamani
Abdullatif Al-Khal
Hassan Mobayed
Maryam Ali Al-Nesf
Tayseer Ibrahim

Frontiers in Allergy

doi 10.3389/falgy.2024.1502285

275 views

Original Research

Published on 24 Dec 2024

Determining the role of basophil activation testing in reported type 1 allergy to beta-lactam antibiotics

in Drug, Venom & Anaphylaxis

Markus Reitmajer
Antonia Strauss
Christian Klinger
Maximiliane Maaß
Wolfgang E. Kempf
Joerg Fischer
Manfred Kneilling
Sebastian Volc

Frontiers in Allergy

doi 10.3389/falgy.2024.1512875

359 views

Editorial

Published on 16 Dec 2024

Editorial: Drug allergy in children

in Drug, Venom & Anaphylaxis

Mara Morelo Rocha Felix
José Laerte Boechat
Fábio Chigres Kuschnir
Mariana C. Castells

Frontiers in Allergy

doi 10.3389/falgy.2024.1530907

211 views

Brief Research Report

Published on 09 Dec 2024

Demographic characteristics associated with a penicillin allergy label during pregnancy

in Drug, Venom & Anaphylaxis

Timothy M. Buckey
Patrick K. Gleeson
Cara M. Curley
Scott F. Feldman
Andrea J. Apter
Olajumoke O. Fadugba

Frontiers in Allergy

doi 10.3389/falgy.2024.1511392

337 views

Case Report

Published on 01 Nov 2024

Case Report: Anaphylaxis caused by traditional Chinese medicine in a patient with pollinosis

in Drug, Venom & Anaphylaxis

Zhouxian Pan
Mengyuan Zhan
Qing Wang
Jun Liu
Yu Li
Fan Zhi
Jing Zhang
Jinhe Liu
Kai Guan
Liping Wen

Frontiers in Allergy

doi 10.3389/falgy.2024.1470638

441 views

Mini Review

Published on 18 Oct 2024

When allergies have no name: is idiopathic anaphylaxis driven by co-factors?

in Drug, Venom & Anaphylaxis

Shuayb Elkhalifa
Haggar Elbashir
Mohamed Abuzakouk

Frontiers in Allergy

doi 10.3389/falgy.2024.1468945

939 views

Case Report

Published on 18 Oct 2024

Case Report: Multidisciplinary management of a patient with indolent systemic mastocytosis and refractory symptoms

in Drug, Venom & Anaphylaxis

Matthew J. Hamilton
Loren W. Greene
Lauren M. Madigan
Sa A. Wang
Cecilia Arana Yi
Andrew Kuykendall
Tracy I. George
Mariana C. Castells

Frontiers in Allergy

doi 10.3389/falgy.2024.1401187

1,216 views

Case Report

Published on 11 Oct 2024

A case report of food-dependent exercise-induced anaphylaxis (FDEIA) treated with omalizumab

in Drug, Venom & Anaphylaxis

Sara Mohamed
Sherin Thalappil
Ramzy Mohamed Ali

Frontiers in Allergy

doi 10.3389/falgy.2024.1472320

864 views

Original Research

Published on 30 Aug 2024

Single center experience with more than 600 drug desensitization in Colombia

in Drug, Venom & Anaphylaxis

Verónica Pardo-Manrique
Luis Fernando Ramírez-Zuluaga
Diana Lucia Silva-Espinosa
Leidy Johanna Hurtado-Bermudez
Inés Elvira Gómez-Hernández
Manuela Olaya-Hernández
Carlos Daniel Serrano-Reyes

Frontiers in Allergy

doi 10.3389/falgy.2024.1460326

694 views

Mini Review

Published on 26 Aug 2024

Rare causes of pediatric anaphylaxis due to obscure allergens

in Drug, Venom & Anaphylaxis

Shajitha Melethil
Ejaz Yousef

Frontiers in Allergy

doi 10.3389/falgy.2024.1456100

1,218 views

Original Research

Published on 06 Aug 2024

Drug fever—an immune-mediated delayed type hypersensitivity reaction to Vinca alkaloids in pediatric oncology patients, possibly mediated by cysteinyl leukotrienes

in Drug, Venom & Anaphylaxis

Mona I. Kidon
Soad Haj Yahia
Gadi Abebe-Campino
Nancy Agmon-Levin
Michal Yelon

Frontiers in Allergy

doi 10.3389/falgy.2024.1361403

739 views

Case Report

Published on 11 Mar 2024

Case Report: Mast cell anergy: absence of symptoms after accidental re-exposure to amoxicillin/clavulanic acid 3 days after anaphylaxis

in Drug, Venom & Anaphylaxis

Loris Guyénard
Marie Tauber
Sophie Debord-Peguet
Frédéric Berard
Audrey Nosbaum
Florence Hacard
Mariana Castells
Jean-François Nicolas

Frontiers in Allergy

doi 10.3389/falgy.2024.1366922

1,826 views

Mini Review

Published on 07 Feb 2024

Recent findings on drug hypersensitivity in children

in Drug, Venom & Anaphylaxis

Mara Morelo Rocha Felix
Fábio Chigres Kuschnir
José Laerte Boechat
Mariana Castells

Frontiers in Allergy

doi 10.3389/falgy.2024.1330517

2,719 views

Brief Research Report

Published on 16 Jan 2024

Feasibility of a drug allergy registry-based excipient allergy database and call for universal mandatory drug ingredient disclosure: the case of PEG

in Drug, Venom & Anaphylaxis

Andy Ka Chun Kan
Valerie Chiang
Chinmoy Saha
Elaine Y. L. Au
Philip Hei Li

Frontiers in Allergy

doi 10.3389/falgy.2023.1331036

1,193 views

Correction

Published on 12 Jan 2024

Corrigendum: Approach for delabeling beta-lactam allergy in children

in Drug, Venom & Anaphylaxis

R. Sáenz de Santa María
G. Bogas
M. Labella
A. Ariza
M. Salas
I. Doña
M. J. Torres

Frontiers in Allergy

doi 10.3389/falgy.2023.1361973

906 views

Review

Published on 14 Dec 2023

Potential and limitations of epitope mapping and molecular targeting in Hymenoptera venom allergy

in Drug, Venom & Anaphylaxis

Luís Gustavo Romani Fernandes
Edzard Spillner
Thilo Jakob

Frontiers in Allergy

doi 10.3389/falgy.2023.1327391

2,560 views
1 citation

Navigation group

Articles

Challenges in diagnosing polyethylene glycol and polysorbate 80 allergies: implications for allergic reactions in COVID-19 mRNA vaccination program: experience from Qatar

Determining the role of basophil activation testing in reported type 1 allergy to beta-lactam antibiotics

Editorial: Drug allergy in children

Demographic characteristics associated with a penicillin allergy label during pregnancy

Case Report: Anaphylaxis caused by traditional Chinese medicine in a patient with pollinosis

When allergies have no name: is idiopathic anaphylaxis driven by co-factors?

Case Report: Multidisciplinary management of a patient with indolent systemic mastocytosis and refractory symptoms

A case report of food-dependent exercise-induced anaphylaxis (FDEIA) treated with omalizumab

Single center experience with more than 600 drug desensitization in Colombia

Rare causes of pediatric anaphylaxis due to obscure allergens

Drug fever—an immune-mediated delayed type hypersensitivity reaction to Vinca alkaloids in pediatric oncology patients, possibly mediated by cysteinyl leukotrienes

Case Report: Mast cell anergy: absence of symptoms after accidental re-exposure to amoxicillin/clavulanic acid 3 days after anaphylaxis

Recent findings on drug hypersensitivity in children

Feasibility of a drug allergy registry-based excipient allergy database and call for universal mandatory drug ingredient disclosure: the case of PEG

Corrigendum: Approach for delabeling beta-lactam allergy in children

Potential and limitations of epitope mapping and molecular targeting in Hymenoptera venom allergy